2 withdrawn. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Withdrawn 2 |
Follow Peripheral blood samples: new trials by email Literature Review of Peripheral blood samples trials Research Report on Peripheral blood samples
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer Pembrolizumab, NEO-PV-01 vaccine, Biopsy - Non Small Cell Lung Cancer, NSCLC | Phase 1 | Withdrawn | Washington University School of Medicine | 2019-04-30 | 2019-04-12 | |
| MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer MCS110, Doxorubicin, Cyclophosphamide - Breast Cancer, Cancer of Breast | Phase 1 | Withdrawn | Washington University School of Medicine | 2018-09-30 | 2018-08-16 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1)
Washington University School of Medicine (2)
Leonel Hernandez-Aya, M.D. (1) · Ramaswamy Govindan, M.D. (1)